Correlation Between Horizon Pharma and Eli Lilly

Can any of the company-specific risk be diversified away by investing in both Horizon Pharma and Eli Lilly at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Horizon Pharma and Eli Lilly into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Horizon Pharma PLC and Eli Lilly and, you can compare the effects of market volatilities on Horizon Pharma and Eli Lilly and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Horizon Pharma with a short position of Eli Lilly. Check out your portfolio center. Please also check ongoing floating volatility patterns of Horizon Pharma and Eli Lilly.

Diversification Opportunities for Horizon Pharma and Eli Lilly

0.0

Correlation Coefficient

Horizon Pharma  Eli Lilly

Pay attention - limited upside

The 3 months correlation between Horizon and Eli is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Horizon Pharma PLC and Eli Lilly and in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eli Lilly and Horizon Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Horizon Pharma PLC are associated (or correlated) with Eli Lilly. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eli Lilly has no effect on the direction of Horizon Pharma i.e., Horizon Pharma and Eli Lilly go up and down completely randomly.

Pair Corralation between Horizon Pharma and Eli Lilly

If you would invest  78,182  in Eli Lilly and on December 27, 2024 and sell it today you would earn a total of  4,494  from holding Eli Lilly and or generate 5.75% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Horizon Pharma PLC  vs.  Eli Lilly and

Horizon Pharma PLC

Risk-Adjusted Performance

Very Weak

Over the last 90 days Horizon Pharma PLC has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Horizon Pharma is not utilizing all of its potentials. The current stock price agitation, may contribute to short-term losses for the retail investors.

Eli Lilly

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Eli Lilly and are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain essential indicators, Eli Lilly may actually be approaching a critical reversion point that can send shares even higher in April 2025.

Pair Trading with Horizon Pharma and Eli Lilly

The main advantage of trading using opposite Horizon Pharma and Eli Lilly positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Horizon Pharma position performs unexpectedly, Eli Lilly can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eli Lilly will offset losses from the drop in Eli Lilly's long position.

The idea behind Horizon Pharma PLC and Eli Lilly and pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.